• In late February 2026, Rocket Lab Corporation reported Q4 and full-year 2025 results showing higher revenue year over year but continued net losses, while also unveiling new silicon-based solar arrays for space data centers, securing a fresh multi-launch agreement with BlackSky, and maintaining guidance for Q1 2026 revenue of US$185 million to US$200 million.
• A successful hypersonic test mission for the Defense Innovation Unit on the HASTE rocket, together with advanced solar power products and expanded BlackSky launch commitments, underscores how Rocket Lab is deepening its role as an end-to-end space infrastructure provider for government and commercial customers.
• Next, we’ll examine how Rocket Lab’s expanding hypersonic testing capabilities and new space power products could reshape the company’s investment narrative.

We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Rocket Lab Investment Narrative Recap

To own Rocket Lab, you need to believe that its launch, hypersonic testing, and space power businesses can eventually support a sustainable, profitable space infrastructure platform despite continued losses and heavy Neutron spending. The latest Q4 update and HASTE success look supportive for near term government and constellation work, but they do not fundamentally change the key near term catalyst (Neutron progress and funding runway) or the biggest risk around ongoing cash burn and potential dilution.

Among the recent announcements, the new silicon based solar arrays stand out because they highlight how Rocket Lab is trying to deepen its space systems offering around power, which sits alongside launch, hypersonics, and satellite platforms. If these power products gain traction, they could reinforce the company’s push to be an end to end provider for large constellations and space based data centers, which is closely tied to future contract wins and backlog visibility.

Yet behind the exciting hypersonic tests and new solar arrays, investors should also be aware of...

Rocket Lab's narrative projects $1.3 billion revenue and $113.4 million earnings by 2028.

Uncover how Rocket Lab's forecasts yield a $83.96 fair value, a 20% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected Rocket Lab to reach about US$1.5 billion of revenue and around US$133 million of earnings by 2028, and they see vertical integration turning “lumpy” government work into higher margin, recurring contracts. If you compare that with the more cautious focus on cash burn and Neutron risk, you can see how far opinions differ and how this new hypersonic and solar news could eventually shift those narratives.

Explore 67 other fair value estimates on Rocket Lab - why the stock might be worth less than half the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Rocket Lab research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Rocket Lab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rocket Lab's overall financial health at a glance.

Interested In Other Possibilities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Find 49 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.